First-line prostate-specific antigen testing with second-line multiparametric MRI was a more cost effective screening strategy for prostate cancer than biparametric MRI as a first-line approach, a study showed.Prior research has tied prostate-specific antigen (PSA) screening for prostate cancer with high rates of overdiagnoses and limited reductions in cancer-specific mortality, Roman Gulati, MS,